Metabolomics Profiling of Kidney, Spleen, Lung, and Liver Tissues in a Mouse Model of Sepsis
Frontiers in Bioscience-Landmark · 2025
DOI: 10.31083/fbl45558 ↗At a glance
Journal article in Frontiers in Bioscience-Landmark, 2025. Written by Moongi Ji and 4 co-authors. Institution: College of Pharmacy and Research Institute of Life and Pharmaceutical Sciences, Sunchon National University, 57922 Suncheon, Republic of Korea. Major MEDLINE topics: Sepsis, Metabolomics, Kidney, Spleen. Cited 2 times so far (Crossref); 55 references. The full text is freely available (open access, CC BY 4.0). Funded by: Ministry of Education, Science, and Technology.
Topics: Sepsis
Abstract (original language)
Background
Sepsis is a life-threatening condition characterized by a dysregulated host response to infection, often leading to multiorgan dysfunction. Despite their clinical importance, early diagnostic biomarkers that reflect organ-specific damage remain inadequately characterized.
Methods
Targeted metabolomic profiling of amino acids, organic acids, fatty acids, nucleosides, and kynurenine pathway metabolites was performed on lung, kidney, spleen, and liver tissues obtained from a lipopolysaccharide-induced mouse model of sepsis, using liquid chromatography-tandem mass spectrometry and gas chromatography-tandem mass spectrometry. Univariate and multivariate statistical analyses (principal component analysis and partial least squares discriminant analysis) were performed to identify potential biomarkers, followed by pathway analysis to elucidate their biological relevance.
Results
Twenty-nine metabolites were significantly altered across the four tissues, exhibiting organ-specific metabolic signatures. Tyrosine, epinephrine, 5-hydroxytryptophan, and kynurenic acid in the kidney; serine, 4-hydroxyproline, normetanephrine, xanthosine, uridine, adenosine, succinic acid, cis-aconitic acid, linoleic acid, and eicosadienoic acid in the spleen; alanine, α-aminobutyric acid, ornithine, uridine, adenosine, 5′-deoxy-5′-methylthioadenosine, succinic acid, and cis-aconitic acid in the lung; and α-aminobutyric acid, pipecolic acid, uridine, inosine, adenosine, glycolic acid, and oxaloacetic acid in the liver were identified as potential biomarkers reflecting organ-specific dysfunction in sepsis.
Conclusions
This study highlights the distinct organ-specific metabolic alterations in sepsis and identifies candidate biomarkers that may reflect early organ dysfunction. These findings provide a foundation for the development of precise diagnostic and medical strategies for sepsis.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- College of Pharmacy and Research Institute of Life and Pharmaceutical Sciences, Sunchon National University, 57922 Suncheon, Republic of Korea.
Funding
- Ministry of Education, Science, and Technology
Cite
APA
Ji, M., Choi, B., Kim, C., Lim, J., & Paik, M. J. (2025). Metabolomics Profiling of Kidney, Spleen, Lung, and Liver Tissues in a Mouse Model of Sepsis. Frontiers in Bioscience-Landmark. https://doi.org/10.31083/fbl45558
Vancouver
Ji M, Choi B, Kim C, Lim J, Paik MJ. Metabolomics Profiling of Kidney, Spleen, Lung, and Liver Tissues in a Mouse Model of Sepsis. Frontiers in Bioscience-Landmark. 2025. doi:10.31083/fbl45558
BibTeX
@article{Ji2025,
author = {Ji, Moongi and Choi, Byeongchan and Kim, Chanho and Lim, Jaeyeop and Paik, Man-Jeong},
title = {Metabolomics Profiling of Kidney, Spleen, Lung, and Liver Tissues in a Mouse Model of Sepsis},
journal = {Frontiers in Bioscience-Landmark},
year = {2025},
doi = {10.31083/fbl45558}
}
EUVIMED